Kestra Medical Technologies, Ltd. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Kestra Medical Technologies, Ltd. (KMTS) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$28.42 million for the 12-month period ending 2025-04-30, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-07-14
- Kestra Medical Technologies, Ltd. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$28.42M.
- Kestra Medical Technologies, Ltd. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$19.76M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-04-30 | -$28.42M 10-K · filed 2026-07-14 |
| 2024-04-30 | -$19.76M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |